Question 1

What is the catalog number for 2019 nCoV/COVID19 RBD domain of spike recombinant protein (S), Biotinylated?

Accepted Answer

The catalog number for 2019 nCoV/COVID19 RBD domain of spike recombinant protein (S), Biotinylated is BSV-COV-PR-47.

Question 2

Is 2019 nCoV/COVID19 RBD domain of spike recombinant protein (S), Biotinylated in stock?

Accepted Answer

2019 nCoV/COVID19 RBD domain of spike recombinant protein (S), Biotinylated is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 4

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 5

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

2019 nCoV/COVID19 RBD domain of spike recombinant protein (S), Biotinylated

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

CD3e (T-Cell Marker) (C3e/2479), CF405S conjugate, 0.1mg/mL

Cytokeratin 18 (KRT18/1190), CF647 conjugate, 0.1mg/mL

CD43 (T-Cell Marker) (rSPN/839), CF405S conjugate, 0.1mg/mL

GFAP (GA-5), CF640R conjugate, 0.1mg/mL

Desmoglein-3 (Squamous Cell Marker) (DSG3/2837), CF594 conjugate, 0.1mg/mL

CD8 (C8/144B), CF740 conjugate, 0.1mg/mL